Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid

Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid

The aim of this study is to learn whether participants find a patient guide to breast cancer treatment decisions acceptable and appropriate for use.

This study seeks to adapt and pilot test de-implementation strategies targeting low-value breast cancer treatments which have persisted despite national recommendations. Breast cancer is an ideal setting in which to study de-implementation given it is common, well-studied, typically presents at an early-stage, and care is provided primarily in a community setting.

Inclusion Criteria

• Early stage breast cancer that is hormone receptor positive (HR+) and human epidermal growth factor negative (HER2-)
• Meet criteria for omission of sentinel lymph node biopsy (SLNB)
• Receiving care at Michigan Medicine

Exclusion Criteria

• Non-English speaking
• Male patients (current data does not support omission of SLNB in men)